Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.08)
# 1,034
Out of 4,667 analysts
21
Total ratings
83.33%
Success rate
40.88%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $180.31 | -2.94% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $106.79 | -43.81% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $25.70 | +172.37% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $120.84 | -4.83% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $96.94 | -17.47% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $2.83 | +2,550.18% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $180.31
Upside: -2.94%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $106.79
Upside: -43.81%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $25.70
Upside: +172.37%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $120.84
Upside: -4.83%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $96.94
Upside: -17.47%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $2.83
Upside: +2,550.18%